Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”
Science Translational Medicine · 2023
DOI: 10.1126/scitranslmed.adh0604 ↗Kurz gefasst
Kommentar in der Zeitschrift Science Translational Medicine, 2023. Verfasst von Eduardo A Albornoz und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St Lucia, QLD 4072, Australia. Hauptthemen laut MEDLINE: Inflammasomes, Parkinson Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
We have replicated our original finding of elevated cleaved caspase-1 in mouse brains and neuroprotection by an NLRP3 inflammasome inhibitor in two mouse models of Parkinson’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Faculty of Medicine, University of Queensland, St Lucia, QLD 4072, Australia.
- UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Herston, QLD 4029, Australia.
- Translational Research Institute, School of Biomedical Science, Centre for Microbiome Research, School of Biomedical Science, Queensland University of Technology, Brisbane QLD 4102, Australia.
- School of Chemistry and Molecular Biosciences, Faculty of Science, University of Queensland, St Lucia, QLD 4072, Australia.
- Institute for Molecular Bioscience (IMB) Centre for Inflammation and Disease Research, University of Queensland, St Lucia, QLD 4072, Australia.
ORCID-Profile: Eduardo A Albornoz, Richard Gordon, Vinod Kumar, Avril A B Robertson, Kate Schroder, Trent M Woodruff
Zitieren
APA
Albornoz, E. A., Gordon, R., Kumar, V., Robertson, A. A. B., Schroder, K., & Woodruff, T. M. (2023). Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adh0604
Vancouver
Albornoz EA, Gordon R, Kumar V, Robertson AAB, Schroder K, Woodruff TM. Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”. Science Translational Medicine. 2023. doi:10.1126/scitranslmed.adh0604
BibTeX
@article{Albornoz2023,
author = {Albornoz, Eduardo A and Gordon, Richard and Kumar, Vinod and Robertson, Avril A B and Schroder, Kate and Woodruff, Trent M},
title = {Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”},
journal = {Science Translational Medicine},
year = {2023},
doi = {10.1126/scitranslmed.adh0604}
}
EUVIMED